Cassava Sciences, Inc.SAVANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-27.2%
5Y CAGR+29.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-27.2%/yr
vs +119.5%/yr prior
5Y CAGR
+29.7%/yr
Recent deceleration
Acceleration
-146.7pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
3.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $26.59M | -61.8% |
| 2024 | $69.64M | -22.1% |
| 2023 | $89.42M | +29.7% |
| 2022 | $68.93M | +177.8% |
| 2021 | $24.81M | +242.1% |
| 2020 | $7.25M | +15.2% |
| 2019 | $6.30M | +112.1% |
| 2018 | $2.97M | -61.0% |
| 2017 | $7.62M | -17.0% |
| 2016 | $9.18M | - |